| Effects of cytosine methylation on transcription factor binding sites YA Medvedeva, AM Khamis, IV Kulakovskiy, W Ba-Alawi, MSI Bhuyan, ... BMC genomics 15 (1), 1-12, 2014 | 270 | 2014 |
| HOCOMOCO: expansion and enhancement of the collection of transcription factor binding sites models IV Kulakovskiy, IE Vorontsov, IS Yevshin, AV Soboleva, AS Kasianov, ... Nucleic acids research 44 (D1), D116-D125, 2016 | 246 | 2016 |
| Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen MP Menden, D Wang, MJ Mason, B Szalai, KC Bulusu, Y Guan, T Yu, ... Nature communications 10 (1), 2674, 2019 | 236 | 2019 |
| ONECUT2 is a driver of neuroendocrine prostate cancer H Guo, X Ci, M Ahmed, JT Hua, F Soares, D Lin, L Puca, A Vosoughi, ... Nature communications 10 (1), 278, 2019 | 155 | 2019 |
| PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies P Smirnov, V Kofia, A Maru, M Freeman, C Ho, N El-Hachem, GA Adam, ... Nucleic acids research 46 (D1), D994-D1002, 2018 | 134 | 2018 |
| GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer Q Wu, W Ba-Alawi, G Deblois, J Cruickshank, S Duan, E Lima-Fernandes, ... Nature communications 11 (1), 4205, 2020 | 125 | 2020 |
| MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis WB Tu, YJ Shiah, C Lourenco, PJ Mullen, D Dingar, C Redel, A Tamachi, ... Cancer cell 34 (4), 579-595. e8, 2018 | 93 | 2018 |
| DASPfind: new efficient method to predict drug–target interactions W Ba-Alawi, O Soufan, M Essack, P Kalnis, VB Bajic Journal of cheminformatics 8, 1-9, 2016 | 90 | 2016 |
| INDIGO–INtegrated data warehouse of MIcrobial GenOmes with examples from the red sea extremophiles I Alam, A Antunes, AA Kamau, W Ba Alawi, M Kalkatawi, U Stingl, ... PloS one 8 (12), e82210, 2013 | 90 | 2013 |
| Epigenetic switch–induced viral mimicry evasion in chemotherapy-resistant breast cancer G Deblois, SAM Tonekaboni, G Grillo, C Martinez, YI Kao, F Tai, I Ettayebi, ... Cancer discovery 10 (9), 1312-1329, 2020 | 75 | 2020 |
| Comparative genomics reveals adaptations of a halotolerant thaumarchaeon in the interfaces of brine pools in the Red Sea D Kamanda Ngugi, J Blom, I Alam, M Rashid, W Ba-Alawi, G Zhang, ... The ISME journal 9 (2), 396-411, 2015 | 72 | 2015 |
| Metabolic traits of an uncultured archaeal lineage-MSBL1-from brine pools of the Red Sea R Mwirichia, I Alam, M Rashid, M Vinu, W Ba-Alawi, A Anthony Kamau, ... Scientific reports 6 (1), 19181, 2016 | 69 | 2016 |
| PRMT5 inhibition disrupts splicing and stemness in glioblastoma P Sachamitr, JC Ho, FE Ciamponi, W Ba-Alawi, FJ Coutinho, ... Nature communications 12 (1), 979, 2021 | 67 | 2021 |
| Statin-induced cancer cell death can be mechanistically uncoupled from prenylation of RAS family proteins R Yu, J Longo, JE van Leeuwen, PJ Mullen, W Ba-Alawi, B Haibe-Kains, ... Cancer research 78 (5), 1347-1357, 2018 | 61 | 2018 |
| Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer KL Thu, J Silvester, MJ Elliott, W Ba-Alawi, MH Duncan, AC Elia, AS Mer, ... Proceedings of the National Academy of Sciences 115 (7), E1570-E1577, 2018 | 60 | 2018 |
| DPubChem: a web tool for QSAR modeling and high-throughput virtual screening O Soufan, W Ba-Alawi, A Magana-Mora, M Essack, VB Bajic Scientific reports 8 (1), 9110, 2018 | 45 | 2018 |
| Integrative pharmacogenomics analysis of patient-derived xenografts AS Mer, W Ba-Alawi, P Smirnov, YX Wang, B Brew, J Ortmann, MS Tsao, ... Cancer Research 79 (17), 4539-4550, 2019 | 37 | 2019 |
| Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids E Prince, J Cruickshank, W Ba-Alawi, K Hodgson, J Haight, C Tobin, ... Nature communications 13 (1), 1466, 2022 | 34 | 2022 |
| PRMT inhibition induces a viral mimicry response in triple-negative breast cancer Q Wu, DY Nie, W Ba-Alawi, YS Ji, ZW Zhang, J Cruickshank, J Haight, ... Nature Chemical Biology 18 (8), 821-830, 2022 | 25 | 2022 |
| Mining chemical activity status from high-throughput screening assays O Soufan, W Ba-Alawi, M Afeef, M Essack, V Rodionov, P Kalnis, VB Bajic PloS one 10 (12), e0144426, 2015 | 25 | 2015 |
Benjamin Haibe-KainsScientist (Principal Investigator), Princess Margaret Cancer Centre, University Health NetworkVahvistettu sähköpostiosoite verkkotunnuksessa uhnresearch.ca
